The one-quarter rule, and the paper that took it apart
The gap between a defensible recommendation and a confident one is where most of the harm in this subject lives.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 4 of 5 of this archive, newest first.
The gap between a defensible recommendation and a confident one is where most of the harm in this subject lives.
Every instrument specification quoted in an advertisement is a best case obtained on a calibration mixture, not on a submitted vial.
Where the curve flattens, what flattens with it, and what does not.
Reported from the sessions, and from the two hours afterwards.
The route did not close because of a rule about peptides.
Reported from the analysis, not from a warning notice.
Follow the resin, not the catalogue.
None of what a checkable identity statement requires is commercially sensitive, and all of it is known to whoever produced the document.
The observation that closes a facility is rarely the dramatic one.
The route did not close because of a rule about peptides.
Follow the resin, not the catalogue.
The supplier has not disputed the finding. It has not explained the gap either.
Three different explanations for the same abnormal number, and how to tell them apart.
Real-world persistence figures, with their definitions stated, because the definitions are doing most of the work.
The observation that closes a facility is rarely the dramatic one.
The document is four pages. Three of them are about dates.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
A reminder that a purity figure is the output of a method, and that methods differ.
What the labels permit, what clinicians do, and the size of the gap between them.
Weight loss reduces bone mineral density at load-bearing sites. Whether that translates into fractures in this population is unmeasured.
We work through a single chromatogram twice, under two integration conventions, and show where the difference comes from.
Reported from the analysis, not from a warning notice.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The evidence base is thin and the document says so, which is to its credit.
The observation that closes a facility is rarely the dramatic one.
Every degradation pathway accelerates by orders of magnitude on reconstitution, because the solvent that lyophilisation removed is the reagent most of them need.
Reported from the analysis, not from a warning notice.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The evidence base is thin and the document says so, which is to its credit.
A proper account of an operation that existed, and of what closing it cost.
What the published pharmacokinetics permit, what the labels state, and where the two diverge.
Rapid weight loss by any means raises gallstone risk. Separating that from a direct drug effect requires a comparator, and the trials have one.
The published ladder exists because a protocol needed a single number. Practice has never followed it exactly, and the regulatory file never assumed it would.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The result is unremarkable. What the report omits is not.
The document is four pages. Three of them are about dates.
The observation that closes a facility is rarely the dramatic one.
The condition on arrival is recorded by some services and not others, and it is one of the more informative lines in a report.
A gel pack has a finite thermal budget, and once it is spent the payload equilibrates with whatever is outside the box. The only question is how long that takes.
Follow the resin, not the catalogue.